PLAUR and melanoma: As a follow-up of our studies, we have used the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 technique to obtain the irreversible clearing of uPAR in A375p and A375M6 human melanoma and in HCT116 colon cancer cell lines.